Young Investigator session: Influenza infection may cause exacerbation of lung fibrosis through collagen deposition

A. Stavrou (Nottingham, United Kingdom)

Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Number: 22

PDF journal article, handout or slidesWebcastMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Stavrou (Nottingham, United Kingdom). Young Investigator session: Influenza infection may cause exacerbation of lung fibrosis through collagen deposition. Lung Science Conference 2014 - Lung Inflammation and Immunity

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LSC 2014 abstract - Influenza infection may cause exacerbation of lung fibrosis through collagen deposition
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014

Young Investigator session: Mechanisms regulating enhanced ?v?6 expression in pulmonary fibrosis
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013


HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders
Source: International Congress 2014 – IPF and surroundings
Year: 2014


Type V collagen induced pulmonary fibrosis in C57Bl/6mice
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

An increased respiratory drive accounts for the severity of dyspnea in systemic sclerosis
Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context
Year: 2013

Task force on chronic interstitial lung disease in immunocompetent children
Source: Eur Respir J 2004; 24 : 686-697
Year: 2004



Ability of the lung clearance index to detect inflammation and infection in preschool children with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015

Serologically assessed elastin degradation is related to force vital capacity in patients with IPF
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013


Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection
Source: Eur Respir Rev, 30 (162) 210194; 10.1183/16000617.0194-2021
Year: 2021



Treatment response in hypersensitivity pneumonitis
Source: International Congress 2016 – Orphan diseases II
Year: 2016


Influenza infection affects the degree of fibrosis and apoptosis in the bleomycin mouse model
Source: Annual Congress 2013 –Interesting research questions
Year: 2013

The 2000 steps a day challenge: A tailored exercise programme for lung fibrosis patients
Source: International Congress 2014 – Latest insights in physical activity, exercise testing and muscles
Year: 2014


Mindfulness-based stress reduction in patients with interstitial lung disease: A pilot study
Source: International Congress 2014 – ILDs 3
Year: 2014

Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Tiotropium attenuates pulmonary inflammation in a novel mouse smoke RSV re-infection model
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014

Deposition of tenascin C and collagen IV in bronchial basement membrane of children with chronic respiratory diseases
Source: International Congress 2014 – Paediatric bronchology
Year: 2014


Young Investigator session: A20 levels in dendritic cells control eosinophilic versus neutrophilic lung inflammation in asthma
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014



Structural lung disease, pulmonary infection and inflammation in infancy is associated with reduced spirometry at school-age in children with cystic fibrosis (CF)
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013


Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015


Young Investigator session: Perinatal antibiotic treatment affects murine microbiota, immune responses, and pathology in models of allergic asthma and hypersensitivity pneumonitis
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013